Anthera Pharmaceuticals Overview

  • Founded
  • 2004

Founded
  • Status
  • Public

  • Employees
  • 21

Employees
  • Stock Symbol
  • ANTH

Stock Symbol
  • Investments
  • 1

Anthera Pharmaceuticals General Information

Description

Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.

Contact Information

Website
www.anthera.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 25801 Industrial Boulevard
  • Suite B
  • Hayward, CA 94545
  • United States
+1 (510) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anthera Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
15.2K

Anthera Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Mar-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016 FY 2015 31-Dec-2015
EV 5,610 17,109 (1,648) 129,260
Revenue 0 0 145 3,185
EBITDA (22,994) (26,593) (55,257) (34,935)
Net Income (23,391) (26,874) (55,523) (35,220)
Total Assets 8,811 3,673 23,471 48,125
Total Debt 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Anthera Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to tr
Biotechnology
Hayward, CA
21 As of 2017
00000
00000000 00000

00000

um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
000000000000000
Durham, NC
000 As of 0000
00000
000000 - 000 00000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat n
0000000000000
San Diego, CA
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anthera Pharmaceuticals Competitors (50)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aerie Pharmaceuticals Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
000000 Formerly VC-backed San Diego, CA 00 000.00 000000&0 000.00
000000 000000 0000 Formerly VC-backed Seattle, WA 00 00000 000000000 00000
000000000 00000000 Corporation Basking Ridge, NJ 00 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000&0 00000
You’re viewing 5 of 50 competitors. Get the full list »

Anthera Pharmaceuticals Patents

Anthera Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170369551-A1 Methods of treating iga nephropathy and henoch-schonlein purpura nephritis using a b-cell activating factor (baff) inhibitor Abandoned 24-Jun-2016 000000000000
US-20110301202-A1 Spla2 inhibitor conjugate compounds and methods of use Abandoned 04-Jun-2010 00000000000
US-20110269786-A1 Treatment of major adverse cardiac events and acute coronary syndrome in diabetic patients using secretory phospholipase a2 (spla2) inhibitor or spla2 inhibitor combination therapies Abandoned 30-Apr-2010 0000000000
CA-2749534-A1 Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia Abandoned 08-Jan-2009 000000000
US-20100204249-A1 Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia Abandoned 08-Jan-2009 A61K45/06 0
To view Anthera Pharmaceuticals’s complete patent history, request access »

Anthera Pharmaceuticals Executive Team (13)

Name Title Board Seat Contact Info
John Thompson Chief Executive Officer & Board Member
Charles Olson Chief Technology Officer
May Liu Chief Accounting Officer, Accounting & Senior Vice President
You’re viewing 3 of 13 executive team members. Get the full list »

Anthera Pharmaceuticals Board Members (15)

Name Representing Role Since
Brent Furse Self Board Member 000 0000
Brian Mueller Self Board Member 000 0000
Christopher Henney Ph.D Self Board Member 000 0000
David Thompson Self Board Member 000 0000
John Thompson Anthera Pharmaceuticals Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Anthera Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anthera Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anthera Pharmaceuticals‘s full profile, request access.

Request a free trial

Anthera Pharmaceuticals Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000 000 14-Jul-2014 000000000 Buildings and Property 0000 0000
To view Anthera Pharmaceuticals’s complete investments history, request access »